Financials LB Pharmaceuticals Inc

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-12 pm EDT			5-day change	1st Jan Change
24.94 ^USD	+1.05%		+5.90%	+12.04%

Mar. 09	Certain Class A Common Stock Warrants of LB Pharmaceuticals Inc are subject to a Lock-Up Agreement Ending on 10-MAR-2026.	CI
Mar. 09	Certain Series B Common Stock Warrants of LB Pharmaceuticals Inc are subject to a Lock-Up Agreement Ending on 10-MAR-2026.	CI

Fiscal Period: December	2024	2025	2026	2027
Net sales ¹	-	-	-	-
Change	-	-	-	-
EBITDA	-	-	-	-
Change	-	-	-	-
EBIT ¹	-	-29.9	-117	-149.4
Change	-	-	-291.13%	-27.69%
Interest Paid	-	-	-	-
Earnings before Tax (EBT) ¹	-	-27.1	-117	-145.7
Change	-	-	-331.55%	-24.57%
Net income ¹	-63.1	-24.88	-109.1	-129.9
Change	-	60.58%	-338.74%	-18.97%
Announcement Date	8/22/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	-	-	-	-	-	-
Change	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-
Change	-	-	-	-	-	-
EBIT ¹	-5.246	-13.38	-17.96	-23.62	-30.21	-36.15
Change	-	-155.06%	-34.25%	-31.48%	-27.9%	-19.68%
Charge d'intérêts	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-3.556	-13.38	-17.96	-23.62	-30.21	-36.15
Change	-	-276.27%	-34.25%	-31.48%	-27.9%	-19.68%
Net income ¹	-3.556	-11.16	-17.96	-23.62	-30.21	-36.15
Change	-	-213.84%	-60.95%	-31.48%	-27.9%	-19.68%
Announcement Date	11/6/25	-	-	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2024	2025	2026	2027
Net Debt ¹	-	-295	-174	-
Change	-	-	41.02%	-
Announcement Date	8/22/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2025	2026	2027
CAPEX ¹	-	-	-
Change	-	-	-
Free Cash Flow (FCF) ¹	-32	-121	-144
Change	-	-278.12%	-19.01%
Announcement Date	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-	-	-	-
EBIT Margin (%)	-	-	-	-	-
EBT Margin (%)	-	-	-	-	-
Net margin (%)	-	-	-	-	-
FCF margin (%)	-	-	-	-	-
FCF / Net Income (%)	-	-	128.63%	110.86%	110.9%
Profitability
ROA	-21.18%	-102.33%	-	-	-
ROE	-63.14%	-206.22%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-
Change	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-
Change	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-
Change	-	-	-	-	-
EPS ¹	-	-6.2	-4.028	-4.05	-3.89
Change	-	-	35.04%	-0.56%	3.95%
Nbr of stocks (in thousands)	-	-	25,299	25,299	25,299
Announcement Date	-	8/22/25	-	-	-